health-and-policy2 hours ago
VA Pushes Psychedelic Therapy for 2.1 Million Veterans Amid Rising Suicide Concerns
The Trump administration is accelerating the use of psychedelics like MDMA and psilocybin for veteran mental health, targeting 2.1 million patients. This initiative follows an April executive order and contrasts with the Biden-era FDA’s 2024 rejection of MDMA for PTSD. While the VA reports 6,488 veteran suicides in 2024, 62% of those individuals were not enrolled in VA healthcare, highlighting a gap in access that new policies aim to address.